Fibromyalgia and Chronic Fatigue syndrome have symptoms which overlap almost completely with Lyme disease and with Mitochondrial Disorders. Personal experience has shown that Lyme testing is inconsistent and incomplete. The treatment for Lyme using antibiotics, the class and dose which promote the lessening of symptoms (to be determined by a Lyme literate physician (Daniel Cameron, MD in MT. Kisco, NY, for one) should be attempted in all cases of suspected Fibromyalgia and Chronic Fatigue, as it could be a tick-borne illness which we are unable to yet identify with our current tests. Both should also be evaluated for mitochondrial malfunction (preferably by C.I.D.E.M. Lab at University Hospital in Cleveland, OH, Dr. Kerr). Once evaluated, if mito defects are found treatment, should support function of the mitochondria in the areas noted to be insufficient.
Treating symptoms without knowing the source of the can be dangerous, lead to drug reaction (especially if the mitochondria is malfunctioning) and end up causing the patient to give up hope of ever being well. If a physician is unwilling to try these two antibiotic therapy under close supervision for 6-8 weeks as well as testing/treating mitochondrial disorders, I believe these 2 entities will be renamed for the disorders for which they are rather than named after their symptoms. These symptoms have a REAL cause. Fibro and CFS are the result of disease, either by an invasive organism or damaged mitochondria. Fibro and CFS are symptoms. These people deserve to be treated for the cause of these symptoms. I ask that you compare the list of symptoms for Lyme and other tick-borne illness and Mitochondrial disorders with those with so called Fibromyalgia and/or CFS and see for your selves the incredible similarities.
I propose a study be done lead by Daniel Cameron, MD and Allen Segal, DO, two experts in the field.
Lisa A Kavanaugh - Comment
This is comment on Notice
Drug Development for Chronic Fatigue Syndrome and Myalgic Encephalomyelitis; Public Workshop
View Comment
Related Comments
View AllPublic Submission Posted: 04/15/2013 ID: FDA-2012-N-0962-0011
Aug 02,2013 11:59 PM ET
Public Submission Posted: 04/16/2013 ID: FDA-2012-N-0962-0042
Aug 02,2013 11:59 PM ET
Public Submission Posted: 04/16/2013 ID: FDA-2012-N-0962-0025
Aug 02,2013 11:59 PM ET
Public Submission Posted: 04/17/2013 ID: FDA-2012-N-0962-0043
Aug 02,2013 11:59 PM ET
Public Submission Posted: 04/16/2013 ID: FDA-2012-N-0962-0028
Aug 02,2013 11:59 PM ET